Sign in

CIK 0001671584 · Non-accelerated filer<br>Smaller reporting company

Aptevo Therapeutics Inc.

Sign in to watch
Ticker
APVO
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
811567056
Phone
206-838-0500
Business address
2401 4TH AVE., SUITE 1050, SEATTLE, WA, 98121
  1. 4 Open-market buy SVP Operations, CMO bought 25,000 shares at $0.76 ($19,000)
  2. 4 Open-market buy Director bought 100,000 shares at $0.76 ($75,520)
  3. 424B5 Offering Prospectus
  4. 10-Q Report Quarterly Report
  5. 8-K Event Results of operations
  6. 4 Open-market buy Board of Directors bought 55,015 shares at $0.83 ($45,861)
  7. 4 Open-market buy Board of Directors bought 10,000 shares at $0.90 ($8,996)
  8. 4 Open-market buy Board of Directors bought 30,000 shares at $0.89 ($26,601)
  9. 4 Open-market buy Board of Directors bought 26,460 shares at $0.90 ($23,740)
  10. 4 Open-market buy Board of Directors bought 14,404 shares at $0.87 ($12,596)
  11. 4 Open-market buy Board of Directors bought 19,136 shares at $0.87 ($16,704)
  12. 4 Open-market buy Board of Directors bought 11,375 shares at $0.85 ($9,662)
  13. 4 Open-market buy Board of Directors bought 14,691 shares at $0.85 ($12,454)
  14. 4 Open-market buy Director bought 18,919 shares at $0.85 ($16,058)
  15. 4 Open-market buy Board of Directors bought 16,667 shares at $0.90 ($15,000)
  16. 4 Open-market buy President and CEO bought 50,000 shares at $0.88 ($44,000)
  17. 4 Open-market buy Board of Directors bought 10,000 shares at $0.85 ($8,481)
  18. 4 Open-market buy Board of Directors bought 50,000 shares at $0.78 ($39,000)
  19. 4 Open-market buy Senior VP, Operations bought 20,000 shares at $0.73 ($14,600)
  20. 4 Derivatives Options or other derivatives

Page 27 of 38 · 742 filings